-
Pfizer: Too Cheap To Miss Out
06 Jun 2024 05:13 GMT
… can see that Pfizer has around 30 patents covering various products with … of the patents expire after 2030, meaning that Pfizer has several years … with my thesis? Pfizer has around 20 patents expiring after 2030, but …
-
Halozyme Announces Issuance Of New European Patent For ENHANZE® Drug Delivery Platform
05 Jun 2024 20:30 GMT
… further strengthens our robust patent estate and extends the … companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly … European countries where the patent is validated.
These forward … the recently issued European patent in European countries and …
-
Hypoparathyroidism Market Report 2032: Epidemiology, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
05 Jun 2024 16:08 GMT
… , Merck Sharp & Dohme, Pfizer, Calithera Biosciences, AbbVie, Bristol-Myers … Merck Sharp & Dohme LLC, Pfizer, Calithera Biosciences, Inc, AbbVie, Bristol … as collaborations, acquisitions, mergers, licensing patent details, and other information for …
-
Hypoxic Ischemic Encephalopathy Market Report 2032: Epidemiology, Pipeline Therapies, Latest Approvals by DelveInsight
05 Jun 2024 15:58 GMT
… Ltd., Johnson & Johnson, Pfizer, Inc., Sanofi, Teva Pharmaceuticals Industries … collaborations, acquisitions, mergers, licensing patent details, and other information for … Ltd., Johnson & Johnson, Pfizer, Inc., Sanofi, Teva Pharmaceuticals Industries …
-
What’s in a drug name? More than you might think.
04 Jun 2024 15:35 GMT
… like Johnson & Johnson, Sanofi, Pfizer, Novartis and Merck & Co … name works from a regulatory, patent, trademark, language, URL availability and branding … he always conducts a preliminary trademark screening of possible names due …
-
Duchenne Muscular Dystrophy Market Size was ~USD 2,150 million in 2023 and anticipated to Grow by 2034 | DelveInsight
04 Jun 2024 12:00 GMT
… Santhera Pharmaceuticals/ReveraGen Biopharma, Pfizer, FibroGen, Capricor Therapeutics, Fibrogen … , acquisitions, mergers, licensing patent details, and other information … /ReveraGen Biopharma
• PF06939926: Pfizer
• Pamrevlumab: FibroGen
• CAP-1002 …
-
Group B Streptococcus Market Report 2040: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight
07 Jun 2024 20:42 GMT
… Marquette University, Minervax ApS, NIAID, Pfizer, Minervax ApS, and others
Key … as collaborations, acquisitions, mergers, licensing patent details, and other information for … Marquette University, Minervax ApS, NIAID, Pfizer, Minervax ApS, and others
Key …
-
Showcasing Seeking Alpha's May 2024 New Analysts
07 Jun 2024 17:28 GMT
… software and AI-related names. Pfizer Inc. (PFE)(PFE:CA) received … up: "Given a complete patent expiration offset, rapid growth of …
-
2 Dividend Stocks Billionaires Are Buying: Should You?
07 Jun 2024 15:21 GMT
… Merck (MRK 0.15%).
1. Pfizer
Pfizer hasn't performed well … that will run out of patent protection soon. That includes … anticoagulant Eliquis, whose patent will expire by the end … likely move past the massive patent cliff ahead. What about …
-
Sarcoidosis Market Size is expected to grow by 2034, estimates DelveInsight
07 Jun 2024 13:09 GMT
… and Key Companies
• Abrocitinib: Pfizer
• Inhaled Treprostinil: United Therapeutics
… , agreements, collaborations, approvals, patents, and advantages, and disadvantages of … 2019-2032
• Sarcoidosis Companies- Pfizer, United Therapeutics, Xentria, Inc., …